| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 21 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 21 |
| 2 | TACROLIMUS OINTMENT 0.1% | 21 |
| 3 | PREDNISONE | 18 |
| 4 | METHOTREXATE SODIUM | 15 |
| 5 | PREDNISOLONE | 15 |
| 6 | PREDNISOLONE ORAL | 15 |
| 7 | PREDNISOLONE ORAL SOLUTION | 15 |
| 8 | METHOTREXATE | 14 |
| 9 | EVEROLIMUS | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | NITAZOXANIDE | 3 | 0.0086 |
| 1 | ALBENDAZOLE | 7 | 0.0037 |
| 2 | PYRIMETHAMINE | 2 | 0.0016 |
| 3 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 9 | 0.0011 |
| 4 | EFAVIRENZ | 11 | 0.0010 |
| 5 | PIOGLITAZONE HYDROCHLORIDE | 1 | 0.0008 |
| 6 | INTERFERON GAMMA-1B | 1 | 0.0007 |
| 7 | EVEROLIMUS TABLETS | 12 | 0.0007 |
| 8 | LAMIVUDINE | 12 | 0.0005 |
| 9 | REMDESIVIR | 6 | 0.0005 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 7 | 0.0024 |
| 1 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 2 | 0.0016 |
| 2 | Interferon gamma [EPC] | 1 | 0.0007 |
| 3 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 13 | 0.0005 |
| 4 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 6 | 0.0005 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 8 | 0.0004 |
| 6 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 8 | 0.0004 |
| 7 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 14 | 0.0003 |
| 8 | Antiprotozoal [EPC] | 3 | 0.0003 |
| 9 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 15 | 0.0001 |